These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29952411)

  • 1. Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents.
    Savić-Radojević A; Mažibrada I; Djukić T; Stanković ZB; Plješa-Ercegovac M; Sedlecky K; Bjekić-Macut J; Simić T; Mastorakos G; Macut D
    Endokrynol Pol; 2018; 69(4):366-374. PubMed ID: 29952411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.
    Savic-Radojevic A; Bozic Antic I; Coric V; Bjekic-Macut J; Radic T; Zarkovic M; Djukic T; Pljesa-Ercegovac M; Panidis D; Katsikis I; Simic T; Macut D
    Hormones (Athens); 2015; 14(1):101-8. PubMed ID: 25402379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.
    Kurdoglu Z; Ozkol H; Tuluce Y; Koyuncu I
    J Endocrinol Invest; 2012 Mar; 35(3):317-21. PubMed ID: 21521935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
    Chen L; Xu WM; Zhang D
    Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y; Fenkci SM; Fenkci V; Oztekin O
    Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.
    Macut D; Simic T; Lissounov A; Pljesa-Ercegovac M; Bozic I; Djukic T; Bjekic-Macut J; Matic M; Petakov M; Suvakov S; Damjanovic S; Savic-Radojevic A
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):451-5. PubMed ID: 21667435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
    Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
    Song DK; Lee H; Hong YS; Sung YA
    BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study.
    Fatima Q; Amin S; Kawa IA; Jeelani H; Manzoor S; Rizvi SM; Rashid F
    Diabetes Metab Syndr; 2019; 13(3):1957-1961. PubMed ID: 31235121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.
    Glueck CJ; Morrison JA; Wang P
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.